Form 4: Brink's Co. EVP and CHRO Elizabeth Galloway Increases Stake Through Deferred Compensation Program
Insider Transaction Report
Elizabeth A. Galloway, Executive Vice President and Chief Human Resources Officer of The Brink's Company, has increased her beneficial ownership of company stock through the reinvestment of dividends into her deferred compensation account.
Summary
- Elizabeth A. Galloway, EVP and CHRO of The Brink's Company (BCO), reported an acquisition of 6 Program Units on June 2, 2025.
- These Program Units are economic equivalents of BCO common stock and were credited to her stock incentive account under the Key Employees' Deferred Compensation Program.
- The acquisition resulted from a dividend payment on BCO common stock.
- The units were valued at $82.14 each, based on the closing price of BCO common stock on June 2, 2025.
- Following this transaction, Ms. Galloway beneficially owns 1,879.85 Program Units directly.
- These Program Units will settle in BCO common stock on a one-for-one basis upon termination of employment or a future selected date.
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as it indicates an executive's continued accumulation of company equity, albeit through a routine dividend reinvestment, which suggests alignment with shareholder interests.
Positives
- An executive increasing their stake, even through a routine dividend reinvestment, can be seen as a positive signal of confidence in the company's long-term prospects.
- The existence of a Key Employees' Deferred Compensation Program indicates a mechanism for aligning executive interests with shareholder value.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the company's future performance. It only details a past transaction.
Management Comments
- Program Units (each of which is the economic equivalent of one share of The Brink's Company ("BCO") common stock) credited to the Reporting Person's stock incentive account under the terms of the Key Employees' Deferred Compensation Program (the "Program") will settle in BCO common stock on a one-for-one basis and shall be distributed in accordance with the Reporting Person's deferral election either (1) following the Reporting Person's termination of employment with BCO or (2) on a future date selected by the Reporting Person at the time of his or her deferral election.
- In accordance with the terms of the Program, Program Units were credited to the Reporting Person's account as a result of a dividend payment with respect to BCO common stock.
Industry Context
This Form 4 reports a routine insider transaction related to executive compensation and dividend reinvestment. It does not provide information that allows for a broad analysis of industry trends or competitors. Such transactions are common across various industries for executive compensation and retention.
Comparison to Industry Standards
- This document does not provide sufficient information to compare The Brink's Company's performance or executive compensation structures to specific global benchmarks or comparable companies. The transaction itself, being a dividend reinvestment into a deferred compensation plan, is a standard practice in many corporate executive compensation programs.
Related Party Transactions
- The transaction involves an executive's participation in a company-sponsored deferred compensation program, which is a standard and disclosed part of executive compensation.
Stakeholder Impact
- Shareholders: The transaction, a routine dividend reinvestment by an executive, may be viewed positively as it aligns executive interests with shareholder value, potentially signaling confidence. However, its direct impact on share price is likely minimal due to its routine nature and small size relative to total shares outstanding.
- Employees: The document pertains to executive compensation and does not directly impact the broader employee base.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Date of transaction where 6 Program Units were acquired and the closing price of BCO common stock ($82.14) was used for valuation. |
| 06/04/2025 | Date the Form 4 was signed by Attorney-in-Fact. |
Keywords
Brink's Company, BCO, Elizabeth Galloway, Form 4, SEC filing, Insider transaction, Beneficial ownership, Deferred compensation, Dividend reinvestment, Executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.